Draper Asset Management LLC Takes $565,000 Position in LENSAR, Inc. (NASDAQ:LNSR)

Draper Asset Management LLC acquired a new position in LENSAR, Inc. (NASDAQ:LNSR - Free Report) during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 40,040 shares of the company's stock, valued at approximately $565,000. LENSAR comprises approximately 0.4% of Draper Asset Management LLC's portfolio, making the stock its 14th largest position. Draper Asset Management LLC owned approximately 0.34% of LENSAR at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also modified their holdings of the company. Atria Investments Inc boosted its stake in LENSAR by 28.2% during the fourth quarter. Atria Investments Inc now owns 26,055 shares of the company's stock worth $233,000 after buying an additional 5,729 shares in the last quarter. Geode Capital Management LLC boosted its stake in shares of LENSAR by 5.6% in the 4th quarter. Geode Capital Management LLC now owns 106,058 shares of the company's stock valued at $948,000 after purchasing an additional 5,627 shares in the last quarter. Huntleigh Advisors Inc. acquired a new stake in shares of LENSAR in the 1st quarter valued at $1,069,000. Renaissance Technologies LLC boosted its stake in shares of LENSAR by 13.3% in the 4th quarter. Renaissance Technologies LLC now owns 348,891 shares of the company's stock valued at $3,119,000 after purchasing an additional 40,946 shares in the last quarter. Finally, Brandes Investment Partners LP boosted its stake in shares of LENSAR by 10.4% in the 4th quarter. Brandes Investment Partners LP now owns 489,318 shares of the company's stock valued at $4,375,000 after purchasing an additional 45,920 shares in the last quarter. Institutional investors and hedge funds own 40.15% of the company's stock.

Wall Street Analyst Weigh In

Several equities research analysts have recently commented on the stock. Lake Street Capital restated a "hold" rating and issued a $15.00 target price (down previously from $16.00) on shares of LENSAR in a research note on Monday, March 24th. BTIG Research downgraded shares of LENSAR from a "strong-buy" rating to a "hold" rating in a research note on Monday, March 24th.

LENSAR Trading Down 0.6%

NASDAQ LNSR traded down $0.08 on Friday, hitting $13.03. 60,893 shares of the company were exchanged, compared to its average volume of 92,908. The firm has a 50 day moving average of $13.26 and a two-hundred day moving average of $12.35. The company has a market cap of $153.62 million, a P/E ratio of -2.69 and a beta of 0.50. LENSAR, Inc. has a 1-year low of $3.50 and a 1-year high of $17.31.

LENSAR (NASDAQ:LNSR - Get Free Report) last issued its quarterly earnings results on Thursday, May 8th. The company reported ($2.32) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.16) by ($2.16). The company had revenue of $11.53 million for the quarter, compared to analyst estimates of $13.40 million. LENSAR had a negative return on equity of 737.30% and a negative net margin of 99.17%.

LENSAR Profile

LENSAR, Inc, a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. It offers LENSAR Laser System that incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, design, and precision.